NeoRegen Biotech
PrivateCompany Overview
NeoRegen Biotech operates in Healthcare & Life Sciences and is based in South Korea. It was founded in 2016.
NeoRegen Biotech is a biotechnology company that develops macromolecule-delivery platform technology for pharmaceuticals, functional cosmetics, and healthcare products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeoRegen Biotech Comparables
Compare NeoRegen Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| REMEDI Co., Ltd. | 83% | |
| Feldan Therapeutics | 79% | |
| Permeasis Therapeutics | 71% |
For institutional investors. Book with your work email.
NeoRegen Biotech Funding Rounds
Historical fundraising activity
NeoRegen Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeoRegen Biotech's valuation, stock price, and market status.
Is NeoRegen Biotech a public or private company?
NeoRegen Biotech is a private company.
What is the current stock price of NeoRegen Biotech?
NeoRegen Biotech is a private company, so its shares have no public market price. Caplight tracks NeoRegen Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeoRegen Biotech worth (valuation)?
Valuation information for NeoRegen Biotech is not publicly available.
Can I buy NeoRegen Biotech stock?
NeoRegen Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeoRegen Biotech's last funding round?
Funding round information for NeoRegen Biotech is not publicly available.
Who are the main investors in NeoRegen Biotech?
Investor information for NeoRegen Biotech is not publicly disclosed.
Will NeoRegen Biotech IPO soon?
No public IPO plans have been announced for NeoRegen Biotech.
How can I track NeoRegen Biotech secondary market activity?
Caplight tracks bids, offers, and trades in NeoRegen Biotech's shares on secondary markets.